Cargando…

Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2

Oxidative stress, inflammation, and hypertension constitute a self-perpetuating vicious circle to exacerbate hypertension and subsequent hypertensive cardiac hypertrophy. NADPH oxidase (Nox) 1/4 inhibitor GKT137831 alleviates hypertensive cardiac hypertrophy in models of secondary hypertension; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Si-yu, Yan, Qiu-jiang, Yang, Li, Mei, Qing-hua, Lu, Hui-qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424508/
https://www.ncbi.nlm.nih.gov/pubmed/32831633
http://dx.doi.org/10.1155/2020/1078365
_version_ 1783570353420763136
author Zeng, Si-yu
Yan, Qiu-jiang
Yang, Li
Mei, Qing-hua
Lu, Hui-qin
author_facet Zeng, Si-yu
Yan, Qiu-jiang
Yang, Li
Mei, Qing-hua
Lu, Hui-qin
author_sort Zeng, Si-yu
collection PubMed
description Oxidative stress, inflammation, and hypertension constitute a self-perpetuating vicious circle to exacerbate hypertension and subsequent hypertensive cardiac hypertrophy. NADPH oxidase (Nox) 1/4 inhibitor GKT137831 alleviates hypertensive cardiac hypertrophy in models of secondary hypertension; however, it remains unclear about its effect on hypertensive cardiac hypertrophy in models of essential hypertension. This study is aimed at determining the beneficial role of GKT137831 in hypertensive cardiac hypertrophy in spontaneously hypertensive rats (SHRs) and its mechanisms of action. Treating with GKT137831 prevented cardiac hypertrophy in SHRs. Likewise, decreasing production of reactive oxygen species (ROS) with GKT137831 reduced epidermal growth factor receptor (EGFR) activity in the left ventricle of SHRs. Additionally, EGFR inhibition also reduced ROS production in the left ventricle and blunted hypertensive cardiac hypertrophy in SHRs. Moreover, inhibition of the ROS-EGFR pathway with Nox1/4 inhibitor GKT137831 or selective EGFR inhibitor AG1478 reduced protein and mRNA levels of proinflammatory cytokines tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and interleukin 1β (IL-1β), as well as the activities of Akt and extracellular signal-regulated kinase (ERK) 1/2 in the left ventricle of SHRs. In summary, GKT137831 prevents hypertensive cardiac hypertrophy in SHRs, Nox-deprived ROS regulated EGFR activation through positive feedback in the hypertrophic myocardium, and inhibition of the ROS-EGFR pathway mediates the protective role of GKT137831 in hypertensive cardiac hypertrophy via repressing cardiac inflammation and activation of Akt and ERK1/2. This research will provide additional details for GKT137831 to prevent hypertensive cardiac hypertrophy.
format Online
Article
Text
id pubmed-7424508
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74245082020-08-20 Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2 Zeng, Si-yu Yan, Qiu-jiang Yang, Li Mei, Qing-hua Lu, Hui-qin Mediators Inflamm Research Article Oxidative stress, inflammation, and hypertension constitute a self-perpetuating vicious circle to exacerbate hypertension and subsequent hypertensive cardiac hypertrophy. NADPH oxidase (Nox) 1/4 inhibitor GKT137831 alleviates hypertensive cardiac hypertrophy in models of secondary hypertension; however, it remains unclear about its effect on hypertensive cardiac hypertrophy in models of essential hypertension. This study is aimed at determining the beneficial role of GKT137831 in hypertensive cardiac hypertrophy in spontaneously hypertensive rats (SHRs) and its mechanisms of action. Treating with GKT137831 prevented cardiac hypertrophy in SHRs. Likewise, decreasing production of reactive oxygen species (ROS) with GKT137831 reduced epidermal growth factor receptor (EGFR) activity in the left ventricle of SHRs. Additionally, EGFR inhibition also reduced ROS production in the left ventricle and blunted hypertensive cardiac hypertrophy in SHRs. Moreover, inhibition of the ROS-EGFR pathway with Nox1/4 inhibitor GKT137831 or selective EGFR inhibitor AG1478 reduced protein and mRNA levels of proinflammatory cytokines tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and interleukin 1β (IL-1β), as well as the activities of Akt and extracellular signal-regulated kinase (ERK) 1/2 in the left ventricle of SHRs. In summary, GKT137831 prevents hypertensive cardiac hypertrophy in SHRs, Nox-deprived ROS regulated EGFR activation through positive feedback in the hypertrophic myocardium, and inhibition of the ROS-EGFR pathway mediates the protective role of GKT137831 in hypertensive cardiac hypertrophy via repressing cardiac inflammation and activation of Akt and ERK1/2. This research will provide additional details for GKT137831 to prevent hypertensive cardiac hypertrophy. Hindawi 2020-08-04 /pmc/articles/PMC7424508/ /pubmed/32831633 http://dx.doi.org/10.1155/2020/1078365 Text en Copyright © 2020 Si-yu Zeng et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zeng, Si-yu
Yan, Qiu-jiang
Yang, Li
Mei, Qing-hua
Lu, Hui-qin
Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
title Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
title_full Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
title_fullStr Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
title_full_unstemmed Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
title_short Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
title_sort inhibition of the ros-egfr pathway mediates the protective action of nox1/4 inhibitor gkt137831 against hypertensive cardiac hypertrophy via suppressing cardiac inflammation and activation of akt and erk1/2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424508/
https://www.ncbi.nlm.nih.gov/pubmed/32831633
http://dx.doi.org/10.1155/2020/1078365
work_keys_str_mv AT zengsiyu inhibitionoftherosegfrpathwaymediatestheprotectiveactionofnox14inhibitorgkt137831againsthypertensivecardiachypertrophyviasuppressingcardiacinflammationandactivationofaktanderk12
AT yanqiujiang inhibitionoftherosegfrpathwaymediatestheprotectiveactionofnox14inhibitorgkt137831againsthypertensivecardiachypertrophyviasuppressingcardiacinflammationandactivationofaktanderk12
AT yangli inhibitionoftherosegfrpathwaymediatestheprotectiveactionofnox14inhibitorgkt137831againsthypertensivecardiachypertrophyviasuppressingcardiacinflammationandactivationofaktanderk12
AT meiqinghua inhibitionoftherosegfrpathwaymediatestheprotectiveactionofnox14inhibitorgkt137831againsthypertensivecardiachypertrophyviasuppressingcardiacinflammationandactivationofaktanderk12
AT luhuiqin inhibitionoftherosegfrpathwaymediatestheprotectiveactionofnox14inhibitorgkt137831againsthypertensivecardiachypertrophyviasuppressingcardiacinflammationandactivationofaktanderk12